These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12184367)

  • 1. Considerations and procedures in the derivation of ATSDR minimal risk levels.
    Wheeler JS; Chou S
    Vaccine; 2002 May; 20 Suppl 3():S51-5. PubMed ID: 12184367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health effects classification and its role in the derivation of minimal risk levels: neurological effects.
    Chou CH; Williams-Johnson M
    Toxicol Ind Health; 1998; 14(3):455-71. PubMed ID: 9569449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hematological effects in the development of minimal risk levels.
    Abadin HG; Murray HE; Wheeler JS
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
    Abadin HG; Chou CH; Llados FT
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of exposure versus body burden data in deriving health guidance values.
    Pohl HR; Abadin HG; Jones DE; De Rosa CT
    J Toxicol Environ Health B Crit Rev; 2007; 10(6):401-15. PubMed ID: 17710608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Risk Level Derivation for Cadmium: Acute and Intermediate Duration Exposures.
    Faroon O; Keith S; Mumtaz M; Ruiz P
    J Exp Clin Toxicol; 2017 Nov; 1(1):1-12. PubMed ID: 34414376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
    Pohl HR; Smith-Simon C; Hicks H
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
    Pohl HR; Luukinen B; Holler JS
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Great lakes research--important human health findings and their impact on ATSDR's Superfund research program.
    Hicks HE; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):49-61. PubMed ID: 12018016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry.
    el-Masri HA; Mumtaz MM; Choudhary G; Cibulas W; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):63-9. PubMed ID: 12018017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing uncertainty in the derivation and application of health guidance values in public health practice. Dioxin as a case study.
    De Rosa CT; Pohl HR; Hansen H; Leonard RC; Holler J; Jones D
    Ann N Y Acad Sci; 1999; 895():348-64. PubMed ID: 10676427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the U.S. Army's health risk assessments for oral exposure to six chemical-warfare agents. Introduction.
    J Toxicol Environ Health A; 2000 Mar; 59(5-6):281-526. PubMed ID: 10742829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.